{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:05:00Z","timestamp":1784768700584,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>To determine neurocognitive function (NCF) profiles of patients with lower grade glioma (LGG) eligible to undergo proton radiotherapy (PRT), and how these relate to clinical and radiological characteristics. PRT is offered to those patients for whom sparing of NCF is considered important given their favorable prognosis. To date it is unknown to which extent their NCF profiles are favorable as well.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A consecutive cohort of 151 LGG patients eligible for PRT according to prevailing Dutch criteria, referred between 2018 and 2023, were assessed with standardized neuropsychological tests prior to PRT. Scores were compared to norm-scores. Composite scores were calculated for the total NCF and 6 separate cognitive domains, and profiles were related to tumor location. Clinical and radiological factors characterizing overall NCF impaired patients were investigated, comparing 3 definitions for impairment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Patients had on average significantly lower NCF than their norm-group, but interindividual variability was large. For 100\/151 patients (66.2%), all cognitive domains were intact, whereas 15\/151 patients (9.9%) displayed multiple domain impairments. Poorer NCF was related to right-sided LGG laterality, larger PRT target volume, no Wait &amp; Scan policy, worse neurological function and worse radiological indices (Fazekas and global cortical atrophy, respectively). LGG involvement of the left temporal and occipital lobes was associated with, respectively, lower verbal memory and processing speed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Prior to PRT, the majority of selected LGG patients display favorable NCF profiles. However, a subgroup showed NCF impairments, with multiple relevant clinical and radiological covariates.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s11060-025-04973-7","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T10:31:49Z","timestamp":1740047509000},"page":"147-156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neurocognitive function in lower grade glioma patients selected for proton radiotherapy: real-world data from a prospective cohort study"],"prefix":"10.1007","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6734-2345","authenticated-orcid":false,"given":"Hiska L.","family":"van der Weide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Buunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke F.","family":"Siebenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes A.","family":"Langendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Bannink-Gawryszuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Bosma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roelien H.","family":"Enting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk","family":"van der Hoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne-Rinck","family":"Jeltema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"Wagemakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob J. M.","family":"Groen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemiek M. E.","family":"Walenkamp-Hageman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Nuver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda C. A.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacoba M.","family":"Spikman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"issue":"3","key":"4973_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s11060-017-2607-5","volume":"135","author":"BK Rasmussen","year":"2017","unstructured":"Rasmussen BK, Hansen S, Laursen RJ et al (2017) Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I-IV in the the Danish Neuro-Oncology Registry. J Neurooncol 135(3):571\u2013579. https:\/\/doi.org\/10.1007\/s11060-017-2607-5","journal-title":"J Neurooncol"},{"issue":"14","key":"4973_CR2","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1056\/NEJMoa1500925","volume":"374","author":"JC Buckner","year":"2016","unstructured":"Buckner JC, Shaw EG, Pugh SL et al (2016) Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma. N Engl J Med 374(14):1344\u20131355. https:\/\/doi.org\/10.1056\/NEJMoa1500925","journal-title":"N Engl J Med"},{"issue":"6","key":"4973_CR3","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S1470-2045(21)00090-5","volume":"22","author":"MJ van den Bent","year":"2021","unstructured":"van den Bent MJ, Tesileanu CMS, Wick W et al (2021) Adjuvant and concurrent temozolomide for 1p\/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053\u2013\u200922054): second interim analysis of a randomised, open-label, phase 3 study. Lancet Oncol 22(6):813\u2013823. https:\/\/doi.org\/10.1016\/S1470-2045(21)00090-5","journal-title":"Lancet Oncol"},{"issue":"23","key":"4973_CR4","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1200\/JCO.21.02543","volume":"40","author":"AB Lassman","year":"2022","unstructured":"Lassman AB, Hoang-Xuan K, Polley M-YC et al (2022) Joint Final Report of EORTC 26951 and RTOG 9402: phase III trials with Procarbazine, Lomustine, and Vincristine Chemotherapy for anaplastic oligodendroglial tumors. J Clin Oncol off J Am Soc Clin Oncol 40(23):2539\u20132545. https:\/\/doi.org\/10.1200\/JCO.21.02543","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"issue":"9343","key":"4973_CR5","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/s0140-6736(02)11398-5","volume":"360","author":"M Klein","year":"2002","unstructured":"Klein M, Heimans JJ, Aaronson NK et al (2002) Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet (London England) 360(9343):1361\u20131368. https:\/\/doi.org\/10.1016\/s0140-6736(02)11398-5","journal-title":"Lancet (London England)"},{"issue":"2","key":"4973_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/neuonc\/noac185","volume":"25","author":"FW Boele","year":"2023","unstructured":"Boele FW, den Otter PWM, Reijneveld JC et al (2023) Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers: a longitudinal study spanning two decades. Neuro Oncol 25(2):351\u2013364. https:\/\/doi.org\/10.1093\/neuonc\/noac185","journal-title":"Neuro Oncol"},{"issue":"1","key":"4973_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nrneurol.2016.185","volume":"13","author":"MT Makale","year":"2017","unstructured":"Makale MT, McDonald CR, Hattangadi-Gluth JA, Kesari S (2017) Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours. Nat Rev Neurol 13(1):52\u201364. https:\/\/doi.org\/10.1038\/nrneurol.2016.185","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"4973_CR8","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.diii.2014.08.001","volume":"95","author":"H Duffau","year":"2014","unstructured":"Duffau H (2014) Diffuse low-grade gliomas and neuroplasticity. Diagn Interv Imaging 95(10):945\u2013955. https:\/\/doi.org\/10.1016\/j.diii.2014.08.001","journal-title":"Diagn Interv Imaging"},{"key":"4973_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.radonc.2021.04.023","volume":"160","author":"C Koutsarnakis","year":"2021","unstructured":"Koutsarnakis C, Neromyliotis E, Komaitis S et al (2021) Effects of brain radiotherapy on cognitive performance in adult low-grade glioma patients: a systematic review. Radiother Oncol J Eur Soc Ther Radiol Oncol 160:202\u2013211. https:\/\/doi.org\/10.1016\/j.radonc.2021.04.023","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"1","key":"4973_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11060-013-1278-0","volume":"116","author":"EJJ Habets","year":"2014","unstructured":"Habets EJJ, Taphoorn MJB, Nederend S et al (2014) Health-related quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivors. J Neurooncol 116(1):161\u2013168. https:\/\/doi.org\/10.1007\/s11060-013-1278-0","journal-title":"J Neurooncol"},{"issue":"1","key":"4973_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11060-017-2503-z","volume":"134","author":"E van Kessel","year":"2017","unstructured":"van Kessel E, Baumfalk AE, van Zandvoort MJE, Robe PA, Snijders TJ (2017) Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumor treatment. J Neurooncol 134(1):9\u201318. https:\/\/doi.org\/10.1007\/s11060-017-2503-z","journal-title":"J Neurooncol"},{"issue":"5","key":"4973_CR12","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/neuonc\/noab275","volume":"24","author":"A-L Lemaitre","year":"2022","unstructured":"Lemaitre A-L, Herbet G, Ng S, Moritz-Gasser S, Duffau H (2022) Cognitive preservation following awake mapping-based neurosurgery for low-grade gliomas: a longitudinal, within-patient design study. Neuro Oncol 24(5):781\u2013793. https:\/\/doi.org\/10.1093\/neuonc\/noab275","journal-title":"Neuro Oncol"},{"issue":"13","key":"4973_CR13","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1200\/JCO.2003.04.172","volume":"21","author":"PD Brown","year":"2003","unstructured":"Brown PD, Buckner JC, O\u2019Fallon JR et al (2003) Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination. J Clin Oncol off J Am Soc Clin Oncol 21(13):2519\u20132524. https:\/\/doi.org\/10.1200\/JCO.2003.04.172","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"issue":"6","key":"4973_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1200\/JCO.2013.53.1830","volume":"32","author":"RS Prabhu","year":"2014","unstructured":"Prabhu RS, Won M, Shaw EG et al (2014) Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98\u2013\u200902. J Clin Oncol off J Am Soc Clin Oncol 32(6):535\u2013541. https:\/\/doi.org\/10.1200\/JCO.2013.53.1830","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"issue":"11","key":"4973_CR15","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/S1470-2045(16)30305-9","volume":"17","author":"JC Reijneveld","year":"2016","unstructured":"Reijneveld JC, Taphoorn MJB, Coens C et al (2016) Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033\u201326033): a randomised, open-label, phase 3 intergroup study. Lancet Oncol 17(11):1533\u20131542. https:\/\/doi.org\/10.1016\/S1470-2045(16)30305-9","journal-title":"Lancet Oncol"},{"issue":"2","key":"4973_CR16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ijrobp.2012.11.031","volume":"85","author":"V Gondi","year":"2013","unstructured":"Gondi V, Hermann BP, Mehta MP, Tome WA (2013) Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors. Int J Radiat Oncol Biol Phys 85(2):348\u2013354. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.11.031","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4973_CR17","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3389\/fonc.2019.00991","volume":"9","author":"J Jaspers","year":"2019","unstructured":"Jaspers J, M\u00e8ndez Romero A, Hoogeman MS et al (2019) Evaluation of the hippocampal normal tissue complication model in a prospective cohort of low Grade Glioma Patients-An analysis within the EORTC 22033 clinical trial. Front Oncol 9:991. https:\/\/doi.org\/10.3389\/fonc.2019.00991","journal-title":"Front Oncol"},{"issue":"4","key":"4973_CR18","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.ijrobp.2005.04.016","volume":"63","author":"NN Laack","year":"2005","unstructured":"Laack NN, Brown PD, Ivnik RJ et al (2005) Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study. Int J Radiat Oncol Biol Phys 63(4):1175\u20131183. https:\/\/doi.org\/10.1016\/j.ijrobp.2005.04.016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"4973_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11060-015-1952-5","volume":"126","author":"JC Sherman","year":"2016","unstructured":"Sherman JC, Colvin MK, Mancuso SM et al (2016) Neurocognitive effects of proton radiation therapy in adults with low-grade glioma. J Neurooncol 126(1):157\u2013164. https:\/\/doi.org\/10.1007\/s11060-015-1952-5","journal-title":"J Neurooncol"},{"issue":"8","key":"4973_CR20","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the Central Nervous System: a summary. Neuro Oncol 23(8):1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"4973_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.radonc.2020.11.004","volume":"154","author":"HL van der Weide","year":"2021","unstructured":"van der Weide HL, Kramer MCA, Scandurra D et al (2021) Proton therapy for selected low grade glioma patients in the Netherlands. Radiother Oncol J Eur Soc Ther Radiol Oncol 154:283\u2013290. https:\/\/doi.org\/10.1016\/j.radonc.2020.11.004","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"4973_CR22","volume-title":"Intelligentie En Leeftijd: Onderzoek Bij Nederlanders Van Twaalf Tot Zevenenzeventig Jaar [Intelligence and age: study on Dutch people from Age 12 to 77]","author":"F Verhage","year":"1964","unstructured":"Verhage F (1964) Intelligentie En Leeftijd: Onderzoek Bij Nederlanders Van Twaalf Tot Zevenenzeventig Jaar [Intelligence and age: study on Dutch people from Age 12 to 77]. Koninklijke Van Gorcum, Van Gorcum"},{"issue":"6","key":"4973_CR23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2340\/16501977-1975","volume":"47","author":"EMP van Loon","year":"2015","unstructured":"van Loon EMP, Heijenbrok-Kal MH, van Loon WS et al (2015) Assessment methods and prevalence of cognitive dysfunction in patients with low-grade glioma: a systematic review. J Rehabil Med 47(6):481\u2013488. https:\/\/doi.org\/10.2340\/16501977-1975","journal-title":"J Rehabil Med"},{"issue":"7","key":"4973_CR24","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S1470-2045(10)70294-1","volume":"12","author":"JS Wefel","year":"2011","unstructured":"Wefel JS, Vardy J, Ahles T, Schagen SB (2011) International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 12(7):703\u2013708. https:\/\/doi.org\/10.1016\/S1470-2045(10)70294-1","journal-title":"Lancet Oncol"},{"key":"4973_CR25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.radonc.2022.01.018","volume":"168","author":"L De Roeck","year":"2022","unstructured":"De Roeck L, van der Weide HL, Eekers DBP et al (2022) The European Particle Therapy Network (EPTN) consensus on the follow-up of adult patients with brain and skull base tumours treated with photon or proton irradiation. Radiother Oncol J Eur Soc Ther Radiol Oncol 168:241\u2013249. https:\/\/doi.org\/10.1016\/j.radonc.2022.01.018","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"6","key":"4973_CR26","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1093\/neuros\/nyy378","volume":"84","author":"MG Hart","year":"2019","unstructured":"Hart MG, Romero-Garcia R, Price SJ, Suckling J (2019) Global effects of focal brain tumors on functional complexity and network robustness: a prospective cohort study. Neurosurgery 84(6):1201\u20131213. https:\/\/doi.org\/10.1093\/neuros\/nyy378","journal-title":"Neurosurgery"},{"issue":"4","key":"4973_CR27","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1162\/netn_a_00103","volume":"3","author":"L Douw","year":"2019","unstructured":"Douw L, van Dellen E, Gouw AA et al (2019) The road ahead in clinical network neuroscience. Netw Neurosci (Cambridge Mass) 3(4):969\u2013993. https:\/\/doi.org\/10.1162\/netn_a_00103","journal-title":"Netw Neurosci (Cambridge Mass)"},{"issue":"3","key":"4973_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s11060-019-03259-z","volume":"144","author":"EJJ Habets","year":"2019","unstructured":"Habets EJJ, Hendriks EJ, Taphoorn MJB et al (2019) Association between tumor location and neurocognitive functioning using tumor localization maps. J Neurooncol 144(3):573\u2013582. https:\/\/doi.org\/10.1007\/s11060-019-03259-z","journal-title":"J Neurooncol"},{"key":"4973_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.radonc.2021.01.004","volume":"157","author":"A Dutz","year":"2021","unstructured":"Dutz A, L\u00fchr A, Agolli L et al (2021) Modelling of late side-effects following cranial proton beam therapy. Radiother Oncol J Eur Soc Ther Radiol Oncol 157:15\u201323. https:\/\/doi.org\/10.1016\/j.radonc.2021.01.004","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"2","key":"4973_CR30","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.radonc.2015.11.009","volume":"118","author":"MEMC Christianen","year":"2016","unstructured":"Christianen MEMC, van der Schaaf A, van der Laan HP et al (2016) Swallowing sparing intensity modulated radiotherapy (SW-IMRT) in head and neck cancer: clinical validation according to the model-based approach. Radiother Oncol J Eur Soc Ther Radiol Oncol 118(2):298\u2013303. https:\/\/doi.org\/10.1016\/j.radonc.2015.11.009","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"4973_CR31","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.radonc.2020.07.056","volume":"151","author":"M Tambas","year":"2020","unstructured":"Tambas M, Steenbakkers RJHM, van der Laan HP et al (2020) First experience with model-based selection of head and neck cancer patients for proton therapy. Radiother Oncol J Eur Soc Ther Radiol Oncol 151:206\u2013213. https:\/\/doi.org\/10.1016\/j.radonc.2020.07.056","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-04973-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-04973-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-04973-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T08:30:10Z","timestamp":1745915410000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-04973-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["4973"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-04973-7","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the University Medical Center Groningen, the Netherlands [METc 2017.478; Research Register 201700619]. Written informed consent was obtained from all individual participants in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}